Top news of the week: 08.09.2021.
Companies And Industries
Scopus Biopharma Flexes Immuno-Oncology Pipeline Following Its Acquisition of Olimmune
Scopus Biopharma recently launched Duet Therapeutics to integrate its immunotherapy assets' management and clinical development with Olimmune.
Biotech Company Takes a Hit After Axing HBV Therapy over Safety Concerns
Shares of Assembly Biosciences have fallen more than 20% in premarket trading after the company discontinued the development of a hepatitis B therapeutic candidate.
Cassava CEO, ‘dazed and confused’, takes to biotech defense handbook by blaming short sellers for woes
The Cassava saga continues as its chief Remi Barbier has come out, guns blazing, against accusations that the biotech may have deliberately misdirected investors on its recent Alzheimer’s ...
Scoop: Inspired by the late Tachi Yamada, Jim Wilson launches new nonprofit targeting underserved ultra-rare diseases
A group of powerhouse biotech leaders is coming together to launch a new nonprofit, one aimed at delivering therapies to rare disease populations they believe pharma is leaving behind. ...
Exelixis Mourns Loss of Two Veteran Execs
Exelixis is mourning the loss of two veteran executives—Dr. Gisela M. Schwab, president, Product Development and Medical Affairs and CMO, and Jon Berndt, senior VP of Sales.
CRISPR 2021
Labroots invites you to the 4th Annual CRISPR Virtual Event ! This event will continue the conversation of the abilities of CRISPR-based editing
Exit of Avidity CMO on cusp of first clinical trial sparks stock rout
Investors are taking the departure of Avidity Biosciences’ chief medical officer badly. After learning Jae Kim had left for personal reasons, just days after giving his notice and on the ...
Kyowa Kirin: Tilting at Gender Equality at the Highest Levels
Between April 2020 and today, the executive board of Kyowa Kiran North America (KKNA) has grown from being predominantly male to a 50/50 gender split.